Evofem Biosciences (EVFM) Misses Q4 EPS by 3c

Evofem Biosciences (OTC: EVFM) reported Q4 EPS of ($0.03). Revenue for the quarter came in at $7.1 million.

For earnings history and earnings-related data on Evofem Biosciences (EVFM) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Active options: MSFT PLTR META GOOGL SOFI MSTR IREN AMC IBM SMCI HOOD AMD